Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Nuance Investments LLC

Nuance Investments LLC lessened its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 13.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,969,166 shares of the company's stock after selling 308,915 shares during the quarter. Henry Schein comprises about 5.5% of Nuance Investments LLC's investment portfolio, making the stock its 5th largest holding. Nuance Investments LLC owned about 1.58% of Henry Schein worth $136,266,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Holocene Advisors LP bought a new stake in shares of Henry Schein in the 3rd quarter valued at about $58,319,000. Southpoint Capital Advisors LP raised its holdings in Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock worth $189,540,000 after purchasing an additional 600,000 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Henry Schein during the third quarter worth $43,740,000. Bank of Montreal Can grew its holdings in shares of Henry Schein by 365.6% in the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock valued at $52,095,000 after buying an additional 558,689 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in shares of Henry Schein in the 4th quarter valued at $34,720,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Insider Buying and Selling at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on HSIC shares. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Barrington Research reissued an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Henry Schein has an average rating of "Moderate Buy" and an average price target of $81.10.

Henry Schein Stock Down 1.1 %

Shares of NASDAQ HSIC traded down $0.78 during mid-day trading on Friday, hitting $68.62. The company had a trading volume of 1,028,798 shares, compared to its average volume of 1,573,330. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a 50-day simple moving average of $74.62 and a two-hundred day simple moving average of $72.64. The company has a market capitalization of $8.52 billion, a PE ratio of 28.24, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the business earned $0.66 earnings per share. The firm's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.